Carol M. Black

19.5k total citations · 4 hit papers
161 papers, 13.9k citations indexed

About

Carol M. Black is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Carol M. Black has authored 161 papers receiving a total of 13.9k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Pathology and Forensic Medicine, 43 papers in Pulmonary and Respiratory Medicine and 41 papers in Molecular Biology. Recurrent topics in Carol M. Black's work include Systemic Sclerosis and Related Diseases (103 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (31 papers) and Connective Tissue Growth Factor Research (26 papers). Carol M. Black is often cited by papers focused on Systemic Sclerosis and Related Diseases (103 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (31 papers) and Connective Tissue Growth Factor Research (26 papers). Carol M. Black collaborates with scholars based in United Kingdom, United States and Canada. Carol M. Black's co-authors include Christopher P. Denton, Shiwen Xu, David Abraham, Andrew Leask, Roland M. du Bois, Alan Holmes, Athol U. Wells, David Abraham, George Bou–Gharios and Robyn J. Barst and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Carol M. Black

159 papers receiving 13.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bosentan Therapy for Pulmonary Arterial Hypertension

2002 2.0k citations Lewis J. Rubin, David B. Badesch et al. profile →
Interstitial Lung Disease in Systemic Sclerosis

2008 815 citations Nicole Goh, Sujal R. Desai et al. American Journal of Respiratory and Critical Care Medicine profile →
Histopathologic Subsets of Fibrosing Alveolitis in Patients with Systemic Sclerosis and Their Relationship to Outcome

2002 545 citations Demosthenes Bouros, Athol U. Wells et al. American Journal of Respiratory and Critical Care Medicine profile →
A multicenter, prospective, randomized, double‐blind, placebo‐controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma

2006 484 citations Nicole Goh, Sujal R. Desai et al. Arthritis & Rheumatism profile →

Peers

Countries citing papers authored by Carol M. Black

Since Specialization

Citations

This map shows the geographic impact of Carol M. Black's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol M. Black with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol M. Black more than expected).

Fields of papers citing papers by Carol M. Black

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol M. Black. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol M. Black. The network helps show where Carol M. Black may publish in the future.

Co-authorship network of co-authors of Carol M. Black

This figure shows the co-authorship network connecting the top 25 collaborators of Carol M. Black. A scholar is included among the top collaborators of Carol M. Black based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol M. Black. Carol M. Black is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Loss of protein kinase Cϵ results in impaired cutaneous wound closure and myofibroblast function 2008 ·Journal of Cell Science ·Andrew Leask, Shiwen Xu, Korsa Khan, Yunliang Chen, Alan Holmes, Mark Eastwood, Christopher P. Denton, Carol M. Black, David Abraham	26
2	Interstitial Lung Disease in Systemic Sclerosis breakdown → 2008 ·American Journal of Respiratory and Critical Care Medicine ·Nicole Goh, Sujal R. Desai, Srihari Veeraraghavan, David M. Hansell, Susan J. Copley, Toby M. Maher, Tamera J. Corte, Clare R. Sander, Jonathan Ratoff, Anand Devaraj, Gracijela Božović, Christopher P. Denton, Carol M. Black, Roland M. du Bois, Athol U. Wells	815
3	CCN2 Is Necessary for Adhesive Responses to Transforming Growth Factor-β1 in Embryonic Fibroblasts 2006 ·Journal of Biological Chemistry ·Shiwen Xu, (unknown), Laura Kennedy, Daphne Pala, Yunliang Chen, Sarah Howat, Elisabetta Renzoni, David E. Carter, George Bou–Gharios, Richard Stratton, Jeremy D. Pearson, Frank Beier, Karen M. Lyons, Carol M. Black, David Abraham, Andrew Leask	136
4	Abstract 2765: Maintenance of Improvement in 6-Minute Walk Distance with Long Term Bosentan Treatment: Results of the BREATHE-1 Open-Label Extension Study 2006 ·Circulation ·David B. Badesch, Robyn J. Barst, Nazzareno Galiè, Carol M. Black, Lewis J. Rubin	2
5	Mechanisms and consequences of fibrosis in systemic sclerosis 2006 ·Nature Clinical Practice Rheumatology ·Christopher P. Denton, Carol M. Black, David Abraham	147
6	Matrix Contraction by Dermal Fibroblasts Requires Transforming Growth Factor-β/Activin-Linked Kinase 5, Heparan Sulfate-Containing Proteoglycans, and MEK/ERK 2005 ·American Journal Of Pathology ·Yunliang Chen, Shiwen Xu, (unknown), Laura Kennedy, Marilyn McLeod, Elisabetta Renzoni, George Bou–Gharios, Sarah A. Wilcox‐Adelman, Paul F. Goetinck, Mark Eastwood, Carol M. Black, David Abraham, Andrew Leask	119
7	Endothelin-1 Promotes Myofibroblast Induction through the ETA Receptor via a rac/Phosphoinositide 3-Kinase/Akt-dependent Pathway and Is Essential for the Enhanced Contractile Phenotype of Fibrotic Fibroblasts 2004 ·Molecular Biology of the Cell ·Shiwen Xu, Yunliang Chen, Christopher P. Denton, Mark Eastwood, Elisabetta Renzoni, George Bou–Gharios, Jeremy D. Pearson, Michael R. Dashwood, Roland M. du Bois, Carol M. Black, Andrew Leask, David Abraham	287
8	Interstitial Vascularity in Fibrosing Alveolitis 2003 ·American Journal of Respiratory and Critical Care Medicine ·Elisabetta Renzoni, David A. Walsh, M Salmon, Athol U. Wells, Piersante Sestini, Andrew G. Nicholson, Srihari Veeraraghavan, Anne E. Bishop, Hanna Romańska, Panagiotis Pantelidis, Carol M. Black, Roland M. du Bois	148
9	Histopathologic Subsets of Fibrosing Alveolitis in Patients with Systemic Sclerosis and Their Relationship to Outcome breakdown → 2002 ·American Journal of Respiratory and Critical Care Medicine ·Demosthenes Bouros, Athol U. Wells, Andrew G. Nicholson, Thomas V. Colby, Vlasis Polychronopoulos, P. Pantelidis, Patricia Haslam, Dimitris Vassilakis, Carol M. Black, Roland M. du Bois	545
10	The Gene for Juvenile Hyaline Fibromatosis Maps to Chromosome 4q21 2002 ·The American Journal of Human Genetics ·Nazneen Rahman, Melanie Dunstan, M. Dawn Teare, Sandra Hanks, Sarah Edkins, Jaime Hughes, Graham R. Bignell, Grazia M.S. Mancini, Wim J. Kleijer, Mary Ellen Campbell, (unknown), Carol M. Black, Nigel Williams, Laura Arbour, Matthew L. Warman, Andrea Superti‐Furga, P. Andrew Futreal, F. Michael Pope	58
11	Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients 2001 ·Journal of Clinical Investigation ·Richard Stratton, Shiwen Xu, Giorgia Martini, A. Holmes, Andrew Leask, Thomas Haberberger, George R. Martin, Carol M. Black, David Abraham	26
12	Tumour necrosis factor-α production in fibrosing alveolitis is macrophage subset specific 2001 ·Respiratory Research ·P. Pantelidis, Deirdre S. McGrath, Anne Marie Southcott, Carol M. Black, Roland M. du Bois	14
13	Soluble thrombomodulin concentration is raised in scleroderma associated pulmonary hypertension 2000 ·Annals of the Rheumatic Diseases ·Richard Stratton, (unknown), Gerry Coghlan, Jeremy D. Pearson, Carol M. Black	19
14	Interferon-? does not improve outcome at one year in patients with diffuse cutaneous scleroderma: Results of a randomized, double-blind, placebo-controlled trial 1999 ·Arthritis & Rheumatism ·Carol M. Black, Alan J. Silman, Ariane L. Herrick, Christopher P. Denton, Helen Wilson, Jason Newman, (unknown), Shiwen Xu	146
15	Bronchoalveolar Lavage Cellularity: Lone Cryptogenic Fibrosing Alveolitis Compared with the Fibrosing Alveolitis of Systemic Sclerosis 1998 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), David M. Hansell, Patricia Haslam, M B Rubens, Jeremy Cailes, Carol M. Black, Roland M. du Bois	95
16	Scleroderma Fibroblasts Show Increased Responsiveness to Endothelial Cell–Derived IL-1 and bFGF 1997 ·Journal of Investigative Dermatology ·Christopher P. Denton, Shiwen Xu, Carol M. Black, (unknown)	27
17	Esophageal Scintigraphy in Systemic Sclerosis: A Simplified Imaging and Reporting Method 1996 ·Journal of Nuclear Medicine Technology ·(unknown), John Buscombe, (unknown), (unknown), Carol M. Black, A. J.W. Hilson	3
18	The aetiopathogenesis of systemic sclerosis 1993 ·Journal of Internal Medicine ·Carol M. Black	31
19	SERUM TYPE III PROCOLLAGEN PEPTIDE CONCENTRATIONS IN SYSTEMIC SCLEROSIS AND RAYNAUD'S PHENOMENON: RELATIONSHIP TO DISEASE ACTIVITY AND DURATION 1989 ·Lara D. Veeken ·Carol M. Black, (unknown), Neil Harrison, (unknown), Laurent Guy	34
20	Family studies in scleroderma (systemic sclerosis) demonstrating an HLA-linked increased chromosomal breakage rate in cultured lymphocytes 1988 ·Human Genetics ·(unknown), Gesa Schwanitz, Max P. Baur, Carol M. Black, Ken I. Welsh, P. K�hnl, Christian Rittner	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact